| Serial Number | 97683391 |
| Word Mark | MB MAINLINE BIOSCIENCES |
| Filing Date | Friday, November 18, 2022 |
| Status | 807 - SU - NON-FINAL ACTION - MAILED |
| Status Date | Monday, December 1, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 26, 2024 |
| NOT AVAILABLE | "BIOSCIENCES" |
| Description of Mark | The mark consists of a stylized blue "M" to the left of a stylized light blue "B" above the stylized blue wording "MAINLINE BIOSCIENCE" above stylized blue Asian characters |
| In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/01/2018 |
| Indication of Colors claimed | The color(s) blue and light blue is/are claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical products development; Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals |
| NOT AVAILABLE | The non-Latin characters in the mark transliterate to "ZHULIU YUAN SHENGWUKEJI" and this means "MAIN SOURCE BIOTECHNOLOGY" in English. |
| Goods and Services | Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor; House mark for pharmaceutical research and development |
| In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/01/2018 |
| In Another Form Statement | The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/01/2018 |
| In Another Form Statement | The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/01/2018 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 9, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Saturday, February 1, 2025 |
| First Use In Commerce Date | Saturday, February 1, 2025 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 9, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, January 1, 2023 |
| First Use In Commerce Date | Sunday, January 1, 2023 |
| Party Name | Mainline Biosciences (Shanghai) Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lingang, Shanghai 201413 CN |
| Party Name | Mainline Biosciences (Shanghai) Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lingang, Shanghai 201413 CN |
| Event Date | Event Description |
| Tuesday, November 22, 2022 | NEW APPLICATION ENTERED |
| Friday, December 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, December 10, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, August 30, 2023 | ASSIGNED TO EXAMINER |
| Friday, September 1, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, September 1, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, September 1, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 1, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 1, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, December 2, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 11, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, January 11, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, January 11, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 11, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, April 11, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, July 17, 2024 | TEAS PETITION TO REVIVE RECEIVED |
| Wednesday, July 17, 2024 | PETITION TO REVIVE-GRANTED |
| Wednesday, July 17, 2024 | NOTICE OF REVIVAL - E-MAILED |
| Wednesday, July 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 24, 2024 | ASSIGNED TO LIE |
| Thursday, October 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 29, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, October 29, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 29, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 29, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, October 29, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 26, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 26, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 7, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, March 7, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Friday, May 30, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, March 7, 2025 | USE AMENDMENT FILED |
| Friday, May 30, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, July 7, 2025 | SU - NON-FINAL ACTION - WRITTEN |
| Monday, July 7, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, July 7, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 7, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 1, 2025 | SU - NON-FINAL ACTION - WRITTEN |
| Monday, December 1, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, December 1, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |